Aptamer-conjugated liposome system for targeting MUC1-positive cancer: an in silico screening approach

被引：0
|
作者：
Md Shakil Ahmed Khan [1 ]
Jiwoo Park [1 ]
Somin Lee [1 ]
Jee-Eun Hwang [1 ]
Chiwoo Oh [2 ]
MinKyu Kim [2 ]
Jeong-Seob Lee [2 ]
Jongyeong Jeon [1 ]
Beomjin Park [1 ]
Shengjun Li [1 ]
Han Na Jung [2 ]
Hyung-Jun Im [1 ]
机构：
[1] Seoul National University,Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology
[2] Seoul National University,Department of Applied Bioengineering, Graduate School of Convergence Science and Technology
[3] Cancer Research Institute,undefined
[4] Seoul National University,undefined
[5] Research Institute for Convergence Science,undefined
[6] Seoul National University,undefined
来源：
Health Nanotechnology | / 1卷 / 1期
关键词：
Chemotherapy; Liposome; Doxorubicin; Aptamer; MUC1 protein; Cancer cells;
D O I：
10.1186/s44301-024-00001-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] MUC1 aptamer-conjugated niclosamide-loaded PLGA-PEG nanoparticles attenuate HIF-1 stabilization upon hypoxia in MCF7 breast cancer cells
    Eskandani, Morteza
    Mohabbat, Ariya
    Karimiyan, Alireza
    Dadashi, Hamed
    Adibkia, Khosro
    Sanaat, Zohreh
    Vandghanooni, Somayeh
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 92
  • [32] Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer
    Rochlitz, C
    Figlin, R
    Squiban, P
    Salzberg, M
    Pless, M
    Herrmann, R
    Tartour, E
    Zhao, YX
    Bizouarne, N
    Baudin, M
    Acres, B
    JOURNAL OF GENE MEDICINE, 2003, 5 (08): : 690 - 699
  • [33] Targeting the MUC1-SEA Module With Antibodies for Ablating Human MUC1 Positive Cancer Cells
    Pichinuk, Edward
    Wreschner, Daniel
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (02) : 224 - 224
  • [34] Systemic Delivery of Aptamer-Conjugated XBP1 siRNA Nanoparticles for Efficient Suppression of HER2+Breast Cancer
    Zhang, Long
    Mu, Chaofeng
    Zhang, Tinghong
    Wang, Yingying
    Wang, Yili
    Fan, Luhui
    Liu, Cong
    Chen, Hao
    Shen, Jianliang
    Wei, Kun
    Li, Huaqiong
    ACS APPLIED MATERIALS & INTERFACES, 2020, 12 (29) : 32360 - 32371
  • [35] Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers
    Shahrad, Shima
    Rajabi, Mohammad
    Javadi, Hamidreza
    Zarchi, Ali Akbar Karimi
    Darvishi, Mohammad Hasan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] Targeting lung cancer cells with MUC1 aptamer-functionalized PLA-PEG nanocarriers
    Shima Shahrad
    Mohammad Rajabi
    Hamidreza Javadi
    Ali Akbar Karimi Zarchi
    Mohammad Hasan Darvishi
    Scientific Reports, 12
  • [37] Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer
    Yaping Lv
    Wei Cang
    Quanfu Li
    Xiaodong Liao
    Mengna Zhan
    Huayun Deng
    Shengze Li
    Wei Jin
    Zhi Pang
    Xingdi Qiu
    Kewen Zhao
    Guoqiang Chen
    Lihua Qiu
    Lei Huang
    Oncogenesis, 8
  • [38] A Novel Bacillus Calmette-Guerin-based Breast Cancer Vaccine that Coexpresses Multiple Tandem Repeats of MUC1 and CD80 Breaks the Immune Tolerance and Inhibits MUC1-Positive Breast Cancer Growth
    Yuan, Shifang
    Shi, Changhong
    Lv, Yonggang
    Wang, Ting
    Wang, Hui
    Han, Wei
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (05) : 607 - 613
  • [39] Anti-MUC1/CD44 Dual-Aptamer-Conjugated Liposomes for Cotargeting Breast Cancer Cells and Cancer Stem Cells
    Kim, Dong-Min
    Kim, Minhee
    Park, Hee-Bin
    Kim, Keun-Sik
    Kim, Dong-Eun
    ACS APPLIED BIO MATERIALS, 2019, 2 (10) : 4622 - 4633
  • [40] Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer
    Lv, Yaping
    Cang, Wei
    Li, Quanfu
    Liao, Xiaodong
    Zhan, Mengna
    Deng, Huayun
    Li, Shengze
    Jin, Wei
    Pang, Zhi
    Qiu, Xingdi
    Zhao, Kewen
    Chen, Guoqiang
    Qiu, Lihua
    Huang, Lei
    ONCOGENESIS, 2019, 8 (12)
12345